Scopus BioPharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$11,609,827 over the previous period. Total operating expenses were $11,714,877.
Profit Margin
| 2018 | 0 | -685.96K | |
|---|---|---|---|
| 2019 | 0 | -2.68M | |
| 2020 | 0 | -11.56M | |
| 2021 | 0 | -27.72M | |
| 2022 | 0 | -11.60M |
SCPS Income Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 2.68M | 15.02M | 7.42M | 463.11K | 277.53K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 11.71M | 27.63M | 10.15M | 2.68M | 685.96K |
Operating income | -11.71M | -27.63M | -10.15M | -2.68M | -685.96K |
Other income (expenses), net | 105.05M | 681.21K | -706.44K | 0 | -685.96K |
Income before tax | -11.71M | -26.95M | -10.86M | -2.68M | -685.96K |
Income tax expense | -105.05K | 774.67K | 706.44K | 1 | 0 |
Net income | -11.60M | -27.72M | -11.56M | -2.68M | -685.96K |
Earnings per share | |||||
Basic EPS | -0.55 | -1.61 | -0.87 | -0.18 | -0.04 |
Diluted EPS | -0.55 | -1.61 | -0.87 | -0.18 | -0.04 |
| Data source | Data source | Data source |